St. Jude Starts Pivotal Depression Trial For Deep Brain Stimulator

St. Jude Medical officially entered the race Feb. 7 to successfully market an implantable neurostimulator for depression, announcing FDA clearance for a pivotal trial testing its Libra deep brain stimulation device for the indication

More from Archive

More from Medtech Insight